Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

EGF-R Positive Non-Small Cell Lung Cancer × osimertinib × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 144 Lung Neoplasms 47 Neoplasms 12 NSCLC 11 Neoplasm Metastasis 10 Brain Neoplasms 10 Carcinoma 8 Bronchial Neoplasms 5 Thoracic Neoplasms 4 Respiratory Tract Neoplasms 3 Respiratory Tract Diseases 3 Neoplasms by Site 3 Meningeal Carcinomatosis 3 Lung Diseases 3 Colorectal Neoplasms 3 Adenocarcinoma of Lung 3 Adenocarcinoma 3 Squamous Cell Carcinoma of Head and Neck 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Noonan Syndrome 2 Non Small Cell Lung Cancer Metastatic 2 Neoplasms, Nerve Tissue 2 Neoplasms by Histologic Type 2 Head and Neck Neoplasms 2 Carcinoma, Squamous Cell 2 Carcinoma, Bronchogenic 2 Breast Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1

Interventions

icotinib 2 osimertinib 1 aflutinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04965701 2023-11-13

FLOWER

Istituto Oncologico Veneto IRCCS

EGF-R Positive Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡